These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 8441471

  • 1. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
    Kekulé AS, Lauer U, Weiss L, Luber B, Hofschneider PH.
    Nature; 1993 Feb 25; 361(6414):742-5. PubMed ID: 8441471
    [Abstract] [Full Text] [Related]

  • 2. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.
    Lauer U, Weiss L, Lipp M, Hofschneider PH, Kekulé AS.
    Hepatology; 1994 Jan 25; 19(1):23-31. PubMed ID: 8276360
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis.
    Caselmann WH.
    J Hepatol; 1995 Jan 25; 22(1 Suppl):34-7. PubMed ID: 7602073
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The synergistic transactivation of the hepatitis B viral (HBV) pregenomic promoter by the E6 protein of human papillomavirus type 16 (HPV-16 E6) with HBV X protein was mediated through the AP1 site of E element in the enhancer I (EnI) in human liver cell.
    Lee DH, Choi BH, Rho HM.
    Biochem Biophys Res Commun; 1999 Nov 25; 265(1):62-6. PubMed ID: 10548491
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression.
    Kim SY, Kim JK, Kim HJ, Ahn JK.
    IUBMB Life; 2005 Sep 25; 57(9):651-8. PubMed ID: 16203685
    [Abstract] [Full Text] [Related]

  • 13. The conserved amino-terminal region (amino acids 1-20) of the hepatitis B virus X protein shows a transrepression function.
    Misra KP, Mukherji A, Kumar V.
    Virus Res; 2004 Oct 25; 105(2):157-65. PubMed ID: 15351489
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts.
    Schuster R, Gerlich WH, Schaefer S.
    Oncogene; 2000 Feb 24; 19(9):1173-80. PubMed ID: 10713705
    [Abstract] [Full Text] [Related]

  • 17. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ, Ki SH, Brooks C, Kim SG.
    Xenobiotica; 2009 Feb 24; 39(2):182-92. PubMed ID: 19255944
    [Abstract] [Full Text] [Related]

  • 18. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors.
    Seto E, Mitchell PJ, Yen TS.
    Nature; 1990 Mar 01; 344(6261):72-4. PubMed ID: 2154703
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.